ISO 13485 Consulting

Canada transitioned to mandatory MDSAP (Medical Device Single Audit Program) for all medical device manufacturers selling in Canada. This means Health Canada no longer conducts its own QMS audits — instead, MDSAP auditing organizations assess your quality management system against ISO 13485 plus the regulatory requirements of participating countries (Canada, USA, Brazil, Australia, Japan). Your ISO 13485 system must be built to satisfy MDSAP audit criteria from day one.

Health Canada's Medical Device Establishment License (MDEL) requirements add obligations beyond ISO 13485 — mandatory problem reporting, recall procedures, and distribution records. The Safe Medical Devices Regulations prescribe classification rules, essential safety requirements, and labelling requirements that your QMS must address. We ensure your system satisfies both the ISO standard and the full spectrum of Canadian regulatory obligations.

For manufacturers targeting multiple markets, your QMS architecture matters enormously. Building for MDSAP from the start means a single audit can satisfy Health Canada, FDA (21 CFR 820), EU MDR, TGA, ANVISA, and MHLW requirements. Retrofitting a Canada-only system to accommodate additional regulatory frameworks is significantly more expensive than building for multi-market compliance initially.

Design controls (Clause 7.3) represent the most demanding aspect of ISO 13485 for many Canadian device manufacturers, particularly startups and small companies transitioning from prototype to production. The requirement for design inputs, outputs, reviews, verification, validation, and transfer creates a structured development process that feels burdensome at first — but prevents costly design failures that can trigger recalls, regulatory actions, and liability exposure.

Software as a Medical Device (SaMD) is a rapidly growing segment in Canada, with hubs in Toronto, Waterloo, Montreal, and Vancouver. ISO 13485 applies to SaMD just as it does to physical devices, but software-specific challenges — agile development workflows, continuous deployment, and cybersecurity requirements — require careful adaptation of the QMS. We help software teams implement ISO 13485 in ways that work with modern development practices, not against them.

Canada's medical device industry includes over 1,500 companies, concentrated in Ontario (Greater Toronto, Ottawa, Kitchener-Waterloo), Quebec (Montreal), Alberta (Calgary, Edmonton), and British Columbia (Vancouver). The sector ranges from multinational corporations to innovative startups developing cutting-edge diagnostics, surgical instruments, and digital health solutions. ISO 13485 certification is the baseline requirement for all of them.

Canadian device manufacturers face unique challenges: proximity to the massive US market creates pressure to satisfy FDA requirements simultaneously, while EU MDR compliance opens European markets but adds significant regulatory complexity. The falling Canadian dollar has made manufacturing in Canada more competitive for export, but only if your QMS supports multi-market regulatory compliance. We build systems that enable market access, not just domestic compliance.

ISO 13485 requires risk management to be integrated throughout your QMS, not treated as a standalone exercise. ISO 14971 (Application of Risk Management to Medical Devices) is the companion standard that defines how to conduct risk analysis, evaluation, control, and post-production monitoring. Your design controls, production processes, supplier management, and CAPA system must all reflect risk-based decision making.

Post-market surveillance is where many Canadian manufacturers underperform. ISO 13485 and Health Canada's mandatory problem reporting requirements demand that you systematically collect and analyse post-market data — complaint trends, adverse events, service records, and literature monitoring. This data feeds back into your risk management file and can trigger design changes, labelling updates, or field safety corrective actions. We build practical post-market surveillance systems that generate actionable intelligence, not just regulatory paperwork.